We found that the cytotoxic T lymphocyte (CTL) initiates a lesion in its target cell that causes the destruction not only of the target cell membrane but also the target cell nucleus. This unique lesion is not a general phenomenon in most other forms of target cell death including Ab+C mediated lysis and lysis mediated by hypotonic shock. Since the major role of the CTL in vivo is the destruction of virally altered (either infectious or oncogenic) cells, we have suggested that this lesion may have significance in increasing the CTL's overall efficiency. The proposed studies will focus on the primary events within the target that lead to the expression of the nuclear lesion. The earliest, quantifiable nuclear change is the sensitivity of the target cell nucleus to nonionic detergents. Therefore early studies will be directed at physical changes in the structural proteins of the nuclear membrane that impart resistance to nonionic detergent. Changes in the phosphorylated state of these proteins are associated with the structural reorganization of the nucleus during cell division. By the use of antisera and labeling studies we will compare the changes in nuclear and other cytoskeletal structural proteins with those observed during mitosis. Thus, we will test the hypothesis that the nuclear lesion is the result of the delivery of an inappropriate signal for cell division from the CTL to the target. Additional experiments will test the hypothesis that the CTL-target interaction can be defined within the CTL, in biochemical and physiological terms, as the receptor-stimulated local accumulation of inositol phosphates which are cleaved leaving a membrane bound diacyl glycerol as initiation site for the local secretion of lytic effector molecules. Preliminary evidence suggests that phorbol diesters may mimic the physiological situation and allow the identification of lytic effector molecules. (LB)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA028533-06
Application #
3168183
Study Section
Immunobiology Study Section (IMB)
Project Start
1980-06-01
Project End
1988-05-31
Budget Start
1985-06-01
Budget End
1986-05-31
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Sabelko-Downes, K A; Russell, J H (2000) The role of fas ligand in vivo as a cause and regulator of pathogenesis. Curr Opin Immunol 12:330-5
Sabelko-Downes, K A; Gimenez, M T; Suvannavejh, G C et al. (2000) Genetic control of pathogenic mechanisms in autoimmune demyelinating disease. J Neuroimmunol 110:168-76
Sabelko-Downes, K A; Russell, J H; Cross, A H (1999) Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. J Neuroimmunol 100:42-52
Sabelko-Downes, K A; Cross, A H; Russell, J H (1999) Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J Exp Med 189:1195-205
Thilenius, A R; Sabelko-Downes, K A; Russell, J H (1999) The role of the antigen-presenting cell in Fas-mediated direct and bystander killing: potential in vivo function of Fas in experimental allergic encephalomyelitis. J Immunol 162:643-50
Sabelko, K A; Kelly, K A; Nahm, M H et al. (1997) Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol 159:3096-9
Rogers, A M; Thilenius, A R; Russell, J H (1997) Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis. J Immunol 159:3140-7
Cook, J R; Wormstall, E M; Hornell, T et al. (1997) Quantitation of the cell surface level of Ld resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo. Immunity 7:233-41
Wang, R; Ciardelli, T L; Russell, J H (1997) Partial signaling by cytokines: cytokine regulation of cell cycle and Fas-dependent, activation-induced death in CD4+ subsets. Cell Immunol 182:152-60
Wang, R; Rogers, A M; Ratliff, T L et al. (1996) CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors. J Immunol 157:2961-8

Showing the most recent 10 out of 33 publications